SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001437749-24-004592
Filing Date
2024-02-16
Accepted
2024-02-16 16:32:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A bhat20240216_sc13da.htm SC 13D/A 37460
  Complete submission text file 0001437749-24-004592.txt   38930
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90624 | Film No.: 24648922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address
Bhat Laxminarayan (Filed by) CIK: 0001818245 (see all company filings)

Type: SC 13D/A